JAMA Oncology

  • Home
  • JAMA Oncology

JAMA Oncology JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed publications.

From JAMA: Prostate cancer is the second most common cancer in older men worldwide, with 3.4 million cases in the US in ...
25/07/2025

From JAMA: Prostate cancer is the second most common cancer in older men worldwide, with 3.4 million cases in the US in 2021.

This JAMA Patient Page describes prostate cancer symptoms, screening, diagnosis, and treatment.

https://ja.ma/4mi3xHH

A risk-reducing mastectomy is cost-effective for women aged 30 to 55 with a lifetime breast cancer risk of 35% or higher...
25/07/2025

A risk-reducing mastectomy is cost-effective for women aged 30 to 55 with a lifetime breast cancer risk of 35% or higher, regardless of carrying BRCA1, BRCA2, or PALB2 variants. https://ja.ma/3IJ1y0m

After induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma, radiotherapy plus adjuvant chemothera...
24/07/2025

After induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma, radiotherapy plus adjuvant chemotherapy was noninferior to concurrent chemoradiotherapy with reduced severe acute toxicities during radiotherapy. https://ja.ma/4m2O7qq

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall s...
23/07/2025

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. https://ja.ma/4m6fRKK

From JAMA: Ovarian cancer is the eighth most common cause of cancer and cancer death in women worldwide. Approximately 2...
22/07/2025

From JAMA: Ovarian cancer is the eighth most common cause of cancer and cancer death in women worldwide. Approximately 21 000 women are diagnosed with ovarian cancer annually in the US, and approximately 80% have advanced-stage ovarian cancer at diagnosis.

This Review summarizes the diagnosis and management of high-grade serous ovarian cancer.

⬇️ See the link in the comments.

Combining immune checkpoint inhibitors with chemotherapy in the first line of treatment for older adults with non–small ...
22/07/2025

Combining immune checkpoint inhibitors with chemotherapy in the first line of treatment for older adults with non–small cell lung cancer can delay mortality but increases the risk of severe adverse events. https://ja.ma/4lQRIYQ

Most viewed this week from JAMA Oncology: Total neoadjuvant therapy (TNT) for stage II/III re**al cancer, despite variat...
21/07/2025

Most viewed this week from JAMA Oncology: Total neoadjuvant therapy (TNT) for stage II/III re**al cancer, despite variations in regimen choice, showed efficacy outcomes in routine clinical practice consistent with clinical trials.

https://ja.ma/40ozgyh

Among two U.S prostate cancer registries, the proportion of patients undergoing prostatectomy for indolent cancer droppe...
21/07/2025

Among two U.S prostate cancer registries, the proportion of patients undergoing prostatectomy for indolent cancer dropped over five-fold from 2010 to 2024. https://ja.ma/4m1bPn8

Review: Research advancements in acute lymphoblastic leukemia (ALL) have led to improved outcomes through the use of tar...
20/07/2025

Review: Research advancements in acute lymphoblastic leukemia (ALL) have led to improved outcomes through the use of targeted therapies and immunotherapies, reducing the reliance on prolonged chemotherapy. https://ja.ma/3GtAT7e

From JAMA: Early-onset gastrointestinal cancers are among the largest subset of early-onset cancers globally. This JAMA ...
19/07/2025

From JAMA: Early-onset gastrointestinal cancers are among the largest subset of early-onset cancers globally.

This JAMA Review summarizes current evidence on early-onset gastrointestinal cancers.

https://ja.ma/4f3c1A2

A woman in her 50s with a history of hemochromatosis, psoriasis, and type 2 diabetes presented with a 3-month history of...
19/07/2025

A woman in her 50s with a history of hemochromatosis, psoriasis, and type 2 diabetes presented with a 3-month history of abdominal pain, weight loss, and a large palpable fixed abdominal mass. What is your diagnosis? https://ja.ma/3TH4Y6d

Most viewed this week from JAMA Oncology: Total neoadjuvant therapy (TNT) for stage II/III re**al cancer, despite variat...
19/07/2025

Most viewed this week from JAMA Oncology: Total neoadjuvant therapy (TNT) for stage II/III re**al cancer, despite variations in regimen choice, showed efficacy outcomes in routine clinical practice consistent with clinical trials.

https://ja.ma/44Pa7Ox

Address


Telephone

+13126707827

Website

Alerts

Be the first to know and let us send you an email when JAMA Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Telephone
  • Alerts
  • Contact The Practice
  • Claim ownership or report listing

  • Want your practice to be the top-listed Clinic?

Share